用户名: 密码: 验证码:
Active-Site Structure Analysis of Recombinant Human Inducible Nitric Oxide Synthase Using Imidazole
详细信息    查看全文
文摘
Nitric oxide synthase catalyzes the pyridine nucleotide-dependentoxidation of L-arginine tonitric oxide and L-citrulline. It is a specializedcytochrome P450 monooxygenase that is sensitive toinhibitionby imidazole. Steady-state kinetic studies on recombinant humaninducible nitric oxide synthase (rH-iNOS) demonstrate that imidazole and 1-phenylimidazole are competitiveand reversible inhibitors versusL-arginine. Structure-activity relationship and pHdependence studies on the inhibition suggest that theneutral form of imidazole may be the preferred species and that theonly modifications allowed withoutthe loss of inhibition are at the N-1 position of imidazole.Optical spectrophotometric studies of rH-iNOS with imidazole and 1-phenylimidazole yielded type II differencespectra exhibiting Kd values of 63± 2 and 28 ± 3 mages/entities/mgr.gif">M, respectively. These values were in goodagreement with the steady-state Ki of95± 10 and 38 ± 4 mages/entities/mgr.gif">M, respectively, and confirms the site ofbinding is at the sixth axial ligand of theheme. Imidazole (2.2 mM) also perturbed theKd of L-arginine from 3.03 ± 0.45to 209 ± 10 mages/entities/mgr.gif">M. Theobserved increase in the Kd forL-arginine is consistent with imidazole being a competitiveinhibitor versusL-arginine. The IC50 values of imidazoleand 1-phenylimidazole were lower in the absence ofexogenousBH4, and both inhibitors also competitively inhibited theBH4-dependent activation of the enzyme.Thesedata taken together suggest that the L-arginine, dioxygen,and the BH4 binding sites are in closeproximityin rH-iNOS. Furthermore, these studies demonstrate the usefulnessof imidazole compounds as activesite probes for recombinant human iNOS.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700